DST teams up with Dr Reddy’s, University of Hyd for anti-psoriatic drugs

G Naga Sridhar Hyderabad | Updated on January 11, 2018 Published on May 23, 2017

The Department of Science and Technology (DST) will work jointly with Dr Reddy’s Laboratories Ltd, University of Hyderabad (UoH) and Dr Reddy’s Institute of Life Sciences (DRILS) for discovery and development of anti-psoriatic drugs.

An agreement was signed by the four partners here on Tuesday.

According to a release issued here today, the DST and DRL sponsored project will work on 12-R-Lipoxygenase as target for the discovery and development of drugs for psoriasis. The project cost is estimated at Rs 190 lakh.

The psoriasis and other skin disorders market is currently about $6-7 billion and expected to be reach $13 billion in the next 10 years.

In the long term, it is proposed to establish a national R&D facility to work on inflammatory disorders.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on May 23, 2017
This article is closed for comments.
Please Email the Editor